New $1 billion bet on eye health, Acuvue contact lenses at the center

Johnson & Johnson is pouring more than $1 billion into its Vision operations in Florida, underscoring the strategic weight of its Acuvue contact lens business as demand for premium daily disposables and astigmatism corrections keeps rising worldwide.

Edited by ad hoc news New Releases & Launches Desk. Reviewed before publication on 06/16/2026 at 4:19 AM ET. Details in the imprint.

Johnson & Johnson is putting fresh attention on its eye-care portfolio, committing more than $1 billion to expand Vision manufacturing in Jacksonville, Florida, with its flagship Acuvue contact lenses right in the middle of that push. The company outlined the investment in a June 15 announcement detailing new packaging and distribution capacity for Acuvue and related eye-care products.

Why Acuvue remains Johnson & Johnson's global contact lens workhorse

Acuvue is Johnson & Johnson's long-running soft contact lens brand, spanning daily disposable lines such as 1-Day Acuvue Moist and Acuvue Oasys 1-Day, as well as lenses designed for astigmatism and presbyopia. The portfolio targets patients who need clear vision correction but prefer the flexibility and hygiene benefits of disposable lenses compared with traditional monthly products, and it is one of the company’s best-known consumer-facing medical device brands worldwide. Over the past decade, Johnson & Johnson Vision has steadily shifted the Acuvue lineup toward premium silicone hydrogel materials and high-oxygen-permeable designs that can support longer hours of comfortable wear, a key demand driver among younger and working-age users.

The latest Jacksonville investment is built around that trend: more capacity for high-volume production and advanced automation to support the growing share of daily disposables in the Acuvue mix. According to the company, the new facilities are intended to boost output and shorten lead times for U.S. and global markets, indicating that Johnson & Johnson is planning for continued demand growth in both developed regions and large emerging markets. Local coverage from Jacksonville underscores that the project is expected to add hundreds of jobs as manufacturing scales up.

Functionally, Acuvue lenses are prescribed by eye-care professionals for standard refractive errors such as myopia and hyperopia, but the brand also includes toric designs for astigmatism and multifocal options for patients with age-related presbyopia. The Acuvue Oasys and Moist families incorporate wetting technologies intended to reduce dryness and lens awareness, and many variants are offered with Class 1 or Class 2 UV-blocking properties, positioning them as a higher-end choice within the soft lens market segment. The official Acuvue site highlights daily disposables and toric lenses as core pillars of the range, reflecting where Johnson & Johnson sees the strongest growth.

Strategically, Acuvue gives Johnson & Johnson a consumer-recognizable brand inside its medical devices division at a time when the company is more streamlined after spinning off its consumer health business into Kenvue. Management has repeatedly emphasized medtech and pharmaceuticals as the two pillars of the remaining group, and Vision - with Acuvue at its core - is one of the more visible, recurring-revenue franchises in that medtech portfolio. Shares of Johnson & Johnson (US4781601046) traded on the NYSE at around $146 on 06/14/2026.

Acuvue contact lenses in brief: key facts

• Product: Acuvue soft contact lenses (including 1-Day Acuvue Moist and Acuvue Oasys lines)
• Manufacturer: Johnson & Johnson
• Category: New Release/Launch-related manufacturing expansion
• Launch date: Acuvue brand introduced in 1987; ongoing line expansions
• MSRP / Price: Varies by lens type and retailer; typically sold in multi-lens boxes through eye-care professionals and online channels
• Availability: Widely available in the U.S. via optometrists, optical chains and e-commerce, and in many international markets
• Target audience: Patients needing vision correction who prefer soft contact lenses, especially daily disposables
• Key differentiator / USP: Broad, premium-focused daily disposable and specialty lens portfolio backed by Johnson & Johnson Vision's global manufacturing network

This article was a.i.-assisted and editorially reviewed. Product information without warranty; prices and availability may change at short notice. Not investment advice and not a buy or sell recommendation. Trading involves risk up to and including the total loss of invested capital.